National

Sep 30, 2013 12:45 PM by Joe Bevans

Breast cancer drug approved

WASHINGTON (AP) - U.S. health officials say they have approved a biotech drug from Roche as the first medicine labeled for the treatment of breast cancer before surgery. The Food and Drug Administration approved Perjeta for women with a form of early-stage breast cancer who face a high risk of having their cancer spread to other parts of the body. Surgery to remove tumors is usually the first step in treating most forms of cancer. Perjeta is the first drug to be approved as a pre-surgical step. The FDA gave the drug accelerated approval based on a study showing women who received the drug as an initial treatment were more likely to be cancer-free 12 weeks later than women who received older drug combinations.

»Comments

More News

National
Story Photo

1 minute ago

Baby Monitors Recalled

Concerns about overheating and rupturing batteries have forced the recall of a dozen different type of baby monitors. The Consumer Product Safety...

Most Popular

Top Videos

1 2 3 4